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Summary
Apoptosis plays an important role in oncogenesis determining
tumor growth and aggressiveness. The aim of  this study was to
examine the relationship between apoptosis, diagnosis and
prognosis in canine mammary tumors. Thirty bitches were
submitted to tumor extirpation and a method of labeling
apoptotic cells, that labels DNA fragments, by terminal
deoxynucleotidyl-tranferase (TdT) mediated by 5 deoxy-uridine-
triphosphate (dUTP) nick and labeling (TUNEL) was used. The
apoptotic cells were counted in ten high power fields (10HPF).
Statistical results showed that when there are more than 30
apoptotic cells/10HPF the prognosis is worse (p= 0,0005). Thus
suggesting that apoptosis can be used as a prognostic marker in
canine breast tumors.
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Introduction
Recently there has been a special
interest shown in the study of bitch
mammary gland tumors due to their
similarity with human breast cancer1,2,3.
Furthermore, the mammary gland is
the most commonly site to be affected
by neoplasias in bitches representing
50.00% of all tumors in this
species3,4,5,6,7,8,9.
Many studies attempt to clarify
the mechanisms of carcinogenesis and
advances in molecular biology and
DNA cloning techniques have helped
in a better understanding of the
complex events which occur during the
malignant transformation of  tumors10.
With this there is hope to develop new
cancer treatments11,12,13 in order to
improve the prognosis of individuals
suffering from cancer 10,14,15.
Several tumors present
activated genes which are not normally
expressed in the adult tissue from
which they originate. The proteins
derived from the expression of these
genes are called tumor markers, and
the detection and measurement of
these proteins are used in medicine for
diagnosis and assessing the evolution
of the tumors16. Much effort has been
made to develop objective methods
to evaluate cellular proliferation and its
relation to the prognosis17, 18.
Recently, molecular alterations,
which are observed in the cells of
cancer patients, started to be
understood and they are linked to the
mechanisms which regulate normal cell
division, survival and cell death19.
Programmed cell death, also known
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as apoptosis, plays an important role
in the determination of  tumor growth
and its aggressiveness20. Thus,
apoptosis has been considered as a
inherent and regulating cellular
mechanism, through which there is a
control between the production of
new cells and the individual capacity
of the self-destruction of the
cells21,22,23,24. An understanding of this
process is of fundamental importance
for man as homeostasis does not only
depend on the ability of the organism
to produce new cells, but also the
individual ability of the cells to destroy
themselves when they become
superfluous or uncoordinated 10,19.
The beginning of the process is
rigidly controlled by numerous
intracellular and extracellular signals
capable of inducing programmed cell
death12, 24. This cellular suicide involves
specific proteases, called caspases,
which are activated by the proteolytic
cleavage as a response to signals which
induce programmed cell death. These
active proteases cleave key proteins
from the cells and kill them rapidly and
orderly19. Regulation of this process is
as complex as the regulation of cellular
growth and it accompanies a series of
biochemical alterations and
morphologic characteristics12, with
morphological alterations of the cell
and the nucleus25.
In relation to cancer, some
researchers still do not believe that
determination of  the apoptosis rate can
be utilized as an independent
prognostic indicator26, but another
group demonstrated that the estimation
of apoptosis can be used as such,
similar to the cellular proliferation rate
and expression of the bcl-2 or p53
proteins20. Therefore, they believe that
measurement of cellular proliferation
and apoptosis may improve the
reliability of the prognosis of tumoral
behavior27 and its utilization might
biologically characterize the tumor28, as
this phenomenon is fundamental in
oncogenesis27.
Apoptosis can be detected by
microscopy, conventional
histopathology, or even evidenced by
special techniques29. A method which
labels fragments of DNA and which
has frequently been used, is that of
terminal deoxynucleotidyl-tranferase
(TdT) mediated by 5 deoxy-uridine-
triphosphate (dUTP). This method
labels the 3-OH ends of DNA
fragments and is known as TUNEL30.
The 3-OH ends resulting from DNA
fragmentation, are labeled with
nucleotides modified by the TdT
enzyme. This enzyme is more selective
in detecting apoptosis than necrotic
cells31. The apoptotic cell count can be
considered as a relation of the
percentage of the tumoral cells present,
that is, as the number of apoptotic cells
per square millimeter of neoplastic
tissue, and it is usually designated as the
apoptotic index (AI)29.
Some researchers consider that,
when the AI is high, the tumor grows
at a slower rate and when it is low, the
tumor grows rapidly21. But taking into
consideration that during tumoral
growth there is an equilibrium between
the proliferation and cellular death, in
which the process of apoptosis is
involved32, the high number of
apoptotic cells will be proportional to
a high cellular proliferation rate and an
unfavorable prognosis27. According to
one study17, the survival of  patients
with mammary carcinomas who have
30 or more apoptotic cells per 10 high
power fields (10HPF), was greater than
patients with a count of less than 30
cells per 10HPF.
In this way, considering the
importance of apoptosis in neoplasias
and the lack of understanding in
relation to its real function in mammary
tumors in bitches, this study aimed to
verify the expression of the apoptotic
markers by the TUNEL method. Its
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study in relation to the tumoral
malignancy showed that the evolution
of these tumors can be predicted, and
so this can be a very useful tool in the
determination of  prognosis of  this
type of tumor which otherwise is
difficult to classify and diagnose.
Material and Method
A total of 30 sections of
neoplastic tissues from bitches that were
attended at the Dr. Halim Atique 
UNIRP Veterinary School were
submitted to surgical ablation of their
tumors during the period of  February
to May 2001. The tumoral fragments,
conserved in formalin and embedded
in paraffin, underwent sectioning with
5 mm of thickness, where one was
dyed with hematoxylin e eosin (HE)
for histopathologic diagnosis and
another was submitted to the TUNEL
technique for the detection of
apoptosis. In order to assess the
prognosis, the bitches were
accompanied for up to six months
after the surgical ablation to observe
the presence of re-incidence or
metastasis. Additionally, the time of
evolution and the macroscopic
characteristics were analyzed according
to the TNM classification1, as well as
post-operative response and  death.
TUNEL technique 
The kit used was the Apoptagfi Plus
Peroxidase in situ Apoptosis detection
Kit (Intergenfi company Discovery
products TM). Labeling of the 3-OH
fragment ends was achieved by TdT
mediated using dUTP. The sections cut
from paraffin blocks were removed
from the paraffin, hydrated and rinsed
in distilled water. Subsequently, the
sections were covered by a quantity of
100ml of proteinase K (diluted in the
proportion of 20 mg/ml of distilled
water) and placed for seven minutes
in an incubator at room temperature.
After the sections were washed in
distilled water (4 times of 2 minutes
each) and immersed in Phosphate
buffer solution (PBS) for 3 minutes.
These preparations were then
immersed in 3.00% hydrogen peroxide
solution for 15 minutes and after
washed with PBS (2 times for 5 minutes
each time) and again put into the
incubator at room temperature for 20
minutes in an equilibration buffer
solution. After removing the excess they
were put with 26.88 ml of a solution
comprised of 6.4 ml of TdT solution
with16 ml of reaction buffer and 4.48
ml bovine serum albumin on a slide
and subsequently left in a humid
chamber at 37o C for 1 hour. Following
this, the material was steeped in stop
wash solution (1 ml/34 ml of distilled
water) for 20 minutes and after washed
with PBS for 3 times of 5 minutes each
time. Anti-digoxygenin was put at a rate
of 30 ml over the sections for 30
minutes and again they were washed
in PBS (4 times for 5 minutes each).
Diluted diaminobenzidine (DAB)
solution (117 ml of  DAB dilution
buffer and 13 ml of  DAB
substrate) was used at the rate of 26
ml per slide and left for 5 to 10
minutes. Thereafter the slides were
washed in running water for 5 minutes
and rinsed in distilled water (3 times
for 1 minute each). After this counter-
staining using Harris Hematoxylin was
performed for 10 seconds, the sections
were washed in running water and
afterwards they were rapidly dipped
in 0.50% ammonia hydroxide solution
and left in running water again for 7
minutes. Finally the slides were
dehydrated and mounted in resin. The
TUNEL technique reaction was
demonstrated by the presence of a
golden-brown coloration which
showed the specific morphological
characteristics of apoptosis 33.
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Results
The histopathologic diagnostic
results of the study group demonstrated
that Malignant Mixed Tumors were the
most commonly observed totaling
47.00% of the total number of cases
followed by carcinomas with a
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these prognostic markers in canine
mammary neoplasias. Thus, the results
obtained from the labeling of apoptosis,
by a similar method to GonzÆles 
CÆmpora20, were analyzed and
compared to the prognosis of the
animal (Figure 4).
The number of apoptotic cells was
compared to the prognosis using the Exact
Fischer Test. This test is used when the
available samples are small. It can be seen
that the possibility of a poor prognosis
for the members of the group was higher
when the apoptosis rate was also seen to
be higher (p value = 0.0005). According
to these data, it was verified that all of the
bitches with more than 30 apoptotic cells
per 10HPF showed a poor prognosis and
not one of them possessed a rate less then
30 apoptotic cells per 10HPF.
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Figure 1
Histopathologic diagnosis of tumors in bitches attended in
UNIRP·s Veterinary Hospital from February to May, 2001
Figure 4
Results of apoptosis labeling of canine mammary neoplasias in
relation to the prognosis of bitches attended in UNIRP·s
Veterinary Hospital from February to May 2001
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Figure 3
Photomicrography of a Benign Mixed Tumor (40X), negative
for the apoptotic cells (<30 apoptotic cells/10HPF)
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Figure 2
Photomicrography of a Malignant Mixed Tumor (40X),
indicating the apoptotic cells in a golden-brown (>30
apoptotic cells/10HPF)
frequency of 40.00%. Benign Mixed
Tumors were only seen in 13.00% of
the canine mammary neoplasias, as is
indicated in Figure 1.
According to Table 1, a relation
among the histopathologic diagnosis,
prognosis and the apoptotic rate of
tumors in this group was observed.
Statistically there was not a positive
correlation between the clinical diagnosis
and the prognosis of  the tumors. The
same situation was seen when the
histopathologic diagnosis was
compared to the number of apoptotic
cells per 10HPF, showing that the
correlation among these data was not
significant.
Apoptosis labeling was
expressed as a number of apoptotic
cells in 10 high power felds, considering
the value to be higher or lower than 30
apoptotic cells per field. The labeling of
the apoptotic cells was demonstrated
by a golden-brown coloring33 as can be
seen in Figures 2 and 3 which were
analyzed in pre-determined areas of  the
histological preparations. These areas
with a characteristic tumoral aspect were
split into 10 fields in the lens at a
magnification of 40 X20.
Statistically the results were
evaluated to clarify the true value of
Discussion and Conclusion
Apoptosis can be considered a
favorable prognostic marker for
individuals with breast neoplasias as,
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Table 1
Diagnosis, apoptotic rate and prognosis of bitches attended in UNIRP·s Veterinary Hospital from February to May, 2001
  Histopathologic Diagnosis Apoptosis Index (cells/10HPF) Prognotic
1 Benign Mixed Tumor < 30 Good
2 Solid Carcinoma > 30 Bad
3 Malignant Mixed Tumor < 30 Good
4 Benign Mixed Tumor > 30 Bad
5 Malignant Mixed Tumor < 30 Good
6 Benign Mixed Tumor < 30 Good
7 Malignant Mixed Tumor < 30 Good
8 Malignant Mixed Tumor > 30 Bad
9 Malignant Mixed Tumor > 30 Bad
10 Malignant Mixed Tumor < 30 Good
11 Malignant Mixed Tumor > 30 Good
12 Malignant Mixed Tumor > 30 Good
13 Tubulo-alveolar Carcinoma < 30 Good
14 Solid Carcinoma > 30 Bad
15 Malignant Mixed Tumor < 30 Good
16 Malignant Mixed Tumor > 30 Bad
17 Malignant Mixed Tumor > 30 Good
18 Malignant Mixed Tumor > 30 Good
19 Malignant Mixed Tumor > 30 Good
20 Solid Carcinoma < 30 Good
21 Benign Mixed Tumor < 30 Good
22 Squirrous Carcinoma < 30 Good
23 Malignant Mixed Tumor < 30 Good
24 Medular Carcinoma > 30 Bad
25 Tubulo-alveolar Carcinoma > 30 Bad
26 Intra-ductal Carcinoma > 30 Bad
27 Tubulo-alveolar Carcinoma < 30 Good
28 Intra-ductal Carcinoma < 30 Good
29 Medular Carcinoma > 30 Bad
30 Medular Carcinoma > 30 Bad
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according to reviewed works10,19,
programmed cell death controls
homeostasis stabilizing the growth and
impeding tumoral evolution. But, as
opposed to this, some researchers
report that during tumoral growth there
is an equilibrium between the
proliferation and programmed cell
death in which the apoptosis process
is involved32. If the presence of a
greater number of apoptotically
marked cells is related to a high rate
of cellular proliferation, this
consequently reflects on a less favorable
prognosis for this individual27. Hence,
it can be inferred that individuals with
a greater number of cells labeled by
apoptosis has a survival rate lower than
those with a lower rate of cells labeled
by apoptosis20.
Furthermore, considering that,
individuals with neoplasias present a
high cellular proliferation rate and that,
so that homeostasis occurs, the control
is achieved by the process termed
apoptosis, which controls the tumoral
cell population. It is concluded that the
higher the number of apoptotic cells
the higher the cellular proliferation, and
with this, of course, the tumoral
aggressiveness.
The results obtained in this study
showed that statistical significance was
detected between apoptosis and
prognosis20, which means that when a
higher number of apoptotic cells is
observed present in neoplasias, a worse
prognosis must be expected (p value
= 0.0005).
According to the obtained
results, in agreement with other
researchers20, 27, who also correlated a
higher number of cells labeled by
apoptosis to the high rate of cellular
proliferation, which is responsible for
the tumoral growth. Therefore, labeling
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Resumo
A apoptose, como evento celular, tem uma participaçªo
importante na tumorigŒnese, determinando o crescimento
tumoral e sua agressividade. O presente estudo, teve como
objetivo, examinar a relaçªo entre a apoptose, o diagnóstico
histopatológico e o prognóstico na neoplasia mamÆria canina.
Trinta cadelas foram submetidas a exØrese tumoral e o fragmento
tumoral submetido ao mØtodo de marcaçªo das cØlulas
apoptóticas, que marca fragmentos de DNA da cØlula em
apoptose, conhecido como desoxinucleotídeo terminal
transferase (TdT) mediado pela 5 desoxiuridina trifosfato
(dUTP) ou TUNEL. As cØlulas em apoptose foram contadas
em 10 campos de maior aumento (10HPF) sendo que os
resultados estatísticos demonstraram uma correlaçªo positiva
entre a apoptose e o prognóstico ruim (p= 0,0005). Dessa forma,
a apoptose pode ser considerada um marcador prognóstico nas
neoplasias mamÆrias caninas.
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